Skip to Main content Skip to Navigation
Journal articles

[Towards better evaluation of antipsychotic drugs].

Abstract : The methodology for evaluating medicinal products is now well established. It is based partly on scientific studies provided in support of marketing application, and also on less rigorous "real-life" studies conducted in a specific healthcare system. The gap between these two methodological perspectives needs to be reduced. In the case of antipsychotic drugs, what is needed most is a better definition of endpoints for efficacy. Recent studies show that symptomatic improvements may enhance patients' insight and, in turn, increase their expectations, with a resulting stagnation of their perceived quality of life. The results of randomized trials are difficult to extrapolate to everyday clinical practice. Epidemiological studies with strict methodologies and conducted by independent bodies should be encouraged.
Complete list of metadata

Cited literature [6 references]  Display  Hide  Download
Contributor : Bruno Falissard Connect in order to contact the contributor
Submitted on : Thursday, March 15, 2012 - 9:11:04 AM
Last modification on : Saturday, June 25, 2022 - 8:49:30 PM
Long-term archiving on: : Monday, June 18, 2012 - 3:15:28 PM


Files produced by the author(s)


  • HAL Id : inserm-00462389, version 1
  • PUBMED : 21171252



Bruno Falissard. [Towards better evaluation of antipsychotic drugs].. Bulletin de l'Académie Nationale de Médecine, Elsevier Masson, 2010, 194 (3), pp.595-602; discussion 602-3. ⟨inserm-00462389⟩



Record views


Files downloads